ABCB1 and cancer: Using the CRISPR/Cas9 system to target the MDR1 gene in the MDR cell lines KBV 200 and HCT-8/V, Yang et al. were able to improve vincristine and doxorubicin sensitivity in MDR cancer cells (Yang et al., 2016a).